Syncope and sudden cardiac arrest: a warning sign or a marker of cardiovascular risk?
Article information
Syncope is common in clinical practice; however, its prognostic significance varies widely. For many patients, particularly those with reflex or orthostatic syncope, the long-term prognosis is favorable. In others, however, transient loss of consciousness may be the first clinical manifestation of an underlying arrhythmic or structural cardiac disorder [1,2]. The clinical challenge is therefore not simply to recognize syncope but to determine whether it represents a benign event or a signal of an underlying condition associated with serious cardiovascular outcomes.
In this issue of the Korean Journal of Internal Medicine, Kim et al. [3] examined the association between a history of syncope and subsequent sudden cardiac arrest (SCA) using the Korean National Health Insurance Service database. The study included more than 4.6 million adults who underwent nationwide health screening and were followed for approximately 9 years. SCA occurred in 21,513 individuals (0.47%). Its incidence was higher among individuals with a history of syncope within the preceding 5 years than among those without syncope (0.96 vs. 0.50 per 1,000 person-years).
The magnitude of this association deserves careful interpretation. The unadjusted hazard ratio (HR) for SCA associated with syncope was 1.91 but decreased to 1.29 after adjustment for demographic, metabolic, and cardiovascular factors. This attenuation is clinically informative. Among individuals with prior syncope, those who subsequently experienced SCA were older, more often male, and had a greater burden of hypertension, diabetes mellitus, chronic kidney disease, heart failure, and atrial fibrillation. Thus, a history of syncope may be better viewed as a clinical risk marker that can reflect an underlying cardiovascular substrate rather than as an isolated determinant of future SCA. Previous studies have similarly shown that syncope can carry prognostic information in selected cardiovascular populations, while prediction of SCA at the individual level remains challenging [4–6].
The timing and clinical context of syncope provide additional insight. The adjusted HRs for SCA were 1.29, 1.30, and 1.36 when syncope had occurred within 5, 3, and 1 year, respectively. Syncope documented during an emergency department visit within the preceding year was associated with an adjusted HR of 1.78. These observations suggest that the information conveyed by syncope may depend not only on its occurrence but also on its recency and clinical presentation. This interpretation is consistent with established approaches to syncope, in which the circumstances of the event, cardiovascular history, physical examination, and electrocardiographic findings are integrated to assess the likelihood of serious outcomes [1,7,8].
The comparison with dizziness is also informative. Dizziness alone was not independently associated with subsequent SCA after multivariable adjustment, whereas syncope retained a modest association. Although administrative diagnostic codes cannot fully characterize either symptom, this contrast suggests that transient loss of consciousness may contain prognostic information beyond that conveyed by a less specific symptom.
Another noteworthy observation was the stronger relative association between syncope and SCA among younger individuals and those without hypertension. The adjusted HRs were 2.17, 1.44, and 1.18 in individuals aged <40, 40–64, and ≥65 years, respectively, with a significant interaction by age. This finding should not be interpreted as indicating a greater absolute SCA risk in younger patients. Rather, syncope may provide a stronger relative risk signal when conventional cardiovascular risk factors are less prevalent. A striking symptom in an apparently low-risk individual may therefore deserve careful etiologic evaluation, even when the baseline absolute risk is low.
The present study has important strengths, including its nationwide design, exceptionally large sample size, long follow-up, and sensitivity analyses according to the timing and clinical setting of syncope. Nevertheless, its findings should be interpreted within the limitations inherent to claims-based research. Syncope was identified using diagnostic codes and could not be classified as reflex, orthostatic, cardiac, or unexplained. This distinction is clinically important because prognosis differs substantially according to the underlying cause of syncope [2]. Similarly, SCA was identified using administrative diagnostic and procedure codes rather than event-level clinical adjudication. Detailed electrocardiographic findings, ventricular function, structural abnormalities, and rhythm-monitoring data were unavailable. Residual confounding and misclassification therefore remain possible.
These limitations also define what the study does—and does not—establish. The observed association does not demonstrate that syncope itself contributes causally to SCA, nor does it justify intensive cardiac testing in every patient with syncope. Rather, the findings reinforce a clinically relevant concept: syncope can be a signal that prompts a search for an underlying substrate associated with future SCA. Previous studies similarly demonstrate that the prognostic significance of syncope depends strongly on its etiology and cardiovascular context [2,4].
The next step should therefore move beyond diagnostic codes and isolated clinical variables toward integrated risk characterization. Traditional clinical risk scores combine features such as age, cardiovascular disease, absence of prodromes, and electrocardiographic abnormalities [7]; however, a recent systematic review and meta-analysis found considerable heterogeneity in their performance and limited high-quality evidence supporting routine reliance on any single clinical decision rule [8]. More recently, electrocardiogram (ECG)-based artificial intelligence models have shown the potential to identify patients with syncope at increased risk of cardiovascular mortality, illustrating how information embedded in routinely acquired ECGs may complement conventional clinical assessments [9]. Future studies integrating the circumstances and timing of syncope with electrocardiography, cardiac imaging, prolonged rhythm monitoring, and, when appropriate, genetic information may enable more individualized risk assessment. The clinical value of syncope lies not simply in the event itself but in what the event may reveal about the patient.
Kim et al. provide large-scale population evidence that a history of syncope is associated with subsequent SCA even after adjustment for multiple cardiovascular risk factors. Their findings suggest that syncope should neither be uniformly regarded as benign nor interpreted in isolation as a determinant of SCA. Its significance depends on timing, clinical context, and the underlying cardiovascular substrate. The most useful question after a syncopal event may therefore not be “Will this patient experience sudden cardiac arrest?” but rather “What caused this patient to lose consciousness, and does that cause identify a clinically important risk?”
Notes
Conflicts of interest
The author discloses no conflicts.
Funding
None
